Cases and Conversations™: Improving Identification and Management of Patients with Congenital Adrenal Hyperplasia (CAH)

Release Date: May 30, 2025

Expiration Date: May 30, 2026

Activity Overview

Congenital adrenal hyperplasia (CAH) is a group of rare autosomal recessive disorders that arise from genetic mutation affecting enzymes involved in cortisol synthesis. Depending on the severity of mutations and the loss of functionality of 21-hydroxylase, CAH can take 2 primary forms: a severe-classical (presenting as salt-wasting or simple virilizing forms), and a mild non-classical. It is important that health care professionals receive education regarding the clinical presentation of CAH and optimal approaches to diagnosis and treatment. This Cases and Conversation activity features expert faculty discussing relevant clinical data and guideline recommendations for diagnosis and management of CAH.

Target Audience

This educational initiative is directed toward all HCPs involved in the care of adult and pediatric patients with CAH, including but not limited to endocrinologists, pediatric endocrinologists, pediatricians, primary care providers, nurses, NPs, PAs, and RNs.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Implement diagnostic algorithms to identify patients with congenital adrenal hyperplasia
• Design individualized management plans using guideline recommendations for patients with congenital adrenal hyperplasia
• Assess clinical trial data for emerging agents for the treatment of congenital adrenal hyperplasia